Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
24.16% $13.31
America/New_York / 26 jan 2023 @ 15:59
FUNDAMENTALS | |
---|---|
MarketCap: | 149.23 mill |
EPS: | -0.0250 |
P/E: | -532.40 |
Earnings Date: | Jan 25, 2023 |
SharesOutstanding: | 11.21 mill |
Avg Daily Volume: | 0.0714 mill |
RATING 2023-01-30 |
---|
B+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | n/a | n/a | n/a | n/a | ||
Gr.Profit | n/a | n/a | n/a | n/a | ||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -532.40 | sector: PE -18.15 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -532.40 | industry: PE -25.74 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 13.27 - 13.35 ( +/- 0.30%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-09-19 | Papandreou George | Sell | 0 | Common Stock, par value $0.0001 per share ("Common Stock") |
2023-09-19 | Papandreou George | Sell | 23 250 | Stock Option (Right to Buy) |
2023-09-19 | Papandreou George | Sell | 6 278 | Stock Option (Right to Buy) |
2023-09-19 | Papandreou George | Sell | 23 622 | Stock Option (Right to Buy) |
2023-09-19 | Papandreou George | Sell | 30 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
81.91 |
Last 97 transactions |
Buy: 6 498 910 | Sell: 566 701 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $13.31 (24.16% ) |
Volume | 0.120 mill |
Avg. Vol. | 0.0714 mill |
% of Avg. Vol | 167.57 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.